Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display

BACKGROUND: There have been significant improvements in Chagas disease therapy and it is now widely accepted that most patients with chronic disease might benefit from therapy. However, there are challenges to monitor drug efficacy and cure for these patients, which are important impediments for cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez Carnero, Luis Antonio, Kuramoto, Andréia, Campos de Oliveira, Léa, Monteiro, Jhonatas Sirino, Setubal, João Carlos, Cunha-Neto, Edécio, Cerdeira Sabino, Ester, Giordano, Ricardo José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851536/
https://www.ncbi.nlm.nih.gov/pubmed/36608168
http://dx.doi.org/10.1371/journal.pntd.0011019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851536/
https://www.ncbi.nlm.nih.gov/pubmed/36608168
http://dx.doi.org/10.1371/journal.pntd.0011019

Ejemplares similares